SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-09-001988
Filing Date
2009-03-06
Accepted
2009-03-06 17:22:09
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K g17975e10vk.htm 10-K 625110
2 EX-10.12 g17975exv10w12.htm EX-10.12 12627
3 EX-10.19 g17975exv10w19.htm EX-10.19 31178
4 EX-10.32 g17975exv10w32.htm EX-10.32 17482
5 EX-23 g17975exv23.htm EX-23 4983
6 EX-31.1 g17975exv31w1.htm EX-31.1 8244
7 EX-31.2 g17975exv31w2.htm EX-31.2 8499
8 EX-32.1 g17975exv32w1.htm EX-32.1 3616
9 EX-32.2 g17975exv32w2.htm EX-32.2 3324
10 GRAPHIC g17975g1757901.gif GRAPHIC 10669
11 GRAPHIC g17975g1757902.gif GRAPHIC 238736
  Complete submission text file 0000950144-09-001988.txt   1060408
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 09664019
SIC: 2836 Biological Products, (No Diagnostic Substances)